ClinicalTrials.gg

Program

remimazolam tosylate

Also written as “Remimazolam Tosilate”, “Remimazolam Tosilate for Injection” and “Remimazolam Tosylate”.

Its studies are led by Jiangsu HengRui Medicine.

Furthest: phase 4, since Dec 6, 202315 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Jiangsu HengRui Medicine151 open or runningphase 4since Dec 6, 2023Oct 22, 2013none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 22, 2013First study: phase 1 study in HealthyFirst studyNCT01970072 · 79 enrolled · China
  2. Feb 15, 2015Phase 2 study in General AnesthesiaNCT02406872 · 144 enrolled · China
  3. Aug 4, 2015Phase 1 study in AnesthesiaNCT03444480 · 8 enrolled · China
  4. Dec 22, 2016Phase 2 study in SedationNCT03003884 · 153 enrolled · China
  5. Sep 16, 2017Phase 3 study in SedationNCT03425474 · 378 enrolled · China
  6. Dec 16, 2018Phase 3 study in SedationNCT03779061 · 388 enrolled · China
  7. Apr 15, 2019Phase 3 study in Anesthesia for Elective Surgery PatientsNCT03921775 · 330 enrolled · China
  8. May 14, 2020Phase 3 study in SedationNCT04400201 · 330 enrolled · China
  9. Aug 11, 2021Phase 2 study in Local Anesthesia Assisted SedationNCT05015361 · 108 enrolled · China
  10. Nov 29, 2021Phase 2 study in Sedation in the ICUNCT05152303 · 60 enrolled · China
  11. Jun 13, 2023Phase 2 study in Sedation in the ICUNCT05913336 · 24 enrolled · China
  12. Dec 6, 20232 phase 4 studiesNCT06169995, NCT06216444
  13. Dec 28, 2023Phase 3 study in Sedation in the ICUNCT06222294 · 214 enrolled · China
  14. Jun 16, 2025Phase 3 study in Operative Sedation of PediatricNCT07036419 · 249 enrolled · China

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 15 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07036419Operative Sedation of Pediatric · China3CompletedMay 27, 2026249
NCT06222294Sedation in the ICU · China3CompletedAug 13, 2024214
NCT06216444Sedation in Non-intubated Diagnostic and Therapeutic Procedures · China4Not yet recruitingMar 2024240
NCT06169995Sedation in the Upper Gastrointestinal Endoscopy · China4CompletedDec 15, 202331
NCT05913336Sedation in the ICU · China2CompletedMar 5, 202524
NCT05152303Sedation in the ICU · China2CompletedApr 2, 202360
NCT05015361Local Anesthesia Assisted Sedation · China2CompletedJun 18, 2021108
NCT04400201Sedation · China3CompletedOct 28, 2020330
NCT03921775Anesthesia for Elective Surgery Patients · China3CompletedDec 30, 2019330
NCT03779061Sedation · China3CompletedSep 20, 2018388
NCT03425474Sedation · China3CompletedNov 10, 2017378
NCT03003884Sedation · China2CompletedMar 2017153
NCT03444480Anesthesia · China1CompletedAug 16, 20148
NCT02406872General Anesthesia · China2CompletedAug 2015144
NCT01970072Healthy · China1CompletedJun 20, 201479

How it is read

Names in the registry

  • “Remimazolam Tosilate”, 12 entries
  • “Remimazolam Tosilate for Injection”, 2 entries
  • “Remimazolam Tosylate”, 2 entries
  • “Remimazolam Tosilate for injection”, 1 entry

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
    remimazolam tosylate (Jiangsu HengRui Medicine): development program | ClinicalTrials.gg